European market leading implant now available in the U.S. COLLINSVILLE, CT., December 23, 2021 — Kelyniam Global, Inc. (OTC: KLYG), a leading manufacturer of custom cranial PEEK implants today announced that it has entered into a strategic licensing agreement with Fin-ceramica faenza spa to market the company’s hydroxyapatite patient specific implant. This bio-mimetic ceramic biomaterial...Read More

Kelyniam Global (OTC:KLYG), a maker of custom cranial implants, today announced results for its third quarter ended September 30, 2021. “Strong quarterly sales growth in Q3 made up for delayed procedures due to the Covid 19 Delta variant that affected scheduling in Q2, resulting in YTD sales being approximately flat to the same period last...Read More

CANTON, CT >> Kelyniam Global (OTC:KLYG), a maker of custom cranial implants, today announced results for its half year ended June 30, 2021. “Period comparisons for 2021 and 2020 are very difficult to evaluate due to the multiple effects of the Covid 19 pandemic in 2020. The second quarter of 2020 results were uniquely affected...Read More

CANTON, CT >> Kelyniam Global (KLYG), a maker of custom cranial implants, has released its financial results for the three months ended March 31, 2021 showing profitability despite pandemic related challenges. The Corporations Q1 financial statements are available here. Ross Bjella, Chairman and CEO said, “Despite the uptick in the second surge of Covid infections...Read More

PUBLISHED: March 30, 2021 at 12:00 am CANTON, CT >> Kelyniam Global (OTC:KLYG), a maker of custom cranial implants, today announced results for its year ended December 31, 2020. “I am pleased to announce that Kelyniam returned to profitability in 2020, reaching a significantmilestone in the third year of our five-year plan. Despite a 2nd...Read More

PUBLISHED: November 16, 2020 at 12:00 am CANTON, CT >> Kelyniam Global (OTC:KLYG), a maker of custom cranial implants, today announced results for its third quarter ended September 30, 2020. “In the third quarter Kelyniam was able to capture pent-up demand and some additional market share leading to significantly increased sales compared to the same...Read More

CANTON, CT: Kelyniam Global (OTC:KLYG), a maker of custom cranial implants, today announced results for its half year ended June 30, 2020. “Despite the Covid 19’s pandemic effects, Kelyniam was able to continue operating profitably and significantly increased sales compared to the same period in 2019,” said Ross Bjella, Kelyniam’s CEO. Financial performance for the...Read More

CANTON, CT >> Kelyniam Global (KLYG), a maker of custom cranial implants, releases financial performance for the first quarter of 2020. Click here to access the report. Read More

Click here to view the 2019 financial statements.Read More

CANTON, CT >> Kelyniam Global (KLYG), a maker of custom cranial implants, released today financial performance for the third quarter of 2019. Revenue rose to $491,745 in Q3, up 27% over the previous quarter and 15% over the same quarter last year. Year to date sales are down 7% over the same period in 2018,...Read More